Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Microbicides news


From To
ICAAC: Study Closes Vicriviroc Story

Merck has halted development of the CCR5 inhibitor vicriviroc for treatment of HIV infection, but the drug may still have a role for pre-exposure prophylaxis or microbicide use.

16 September 2010
MedPage Today
Why won’t AIDS donors confirm their best new hope for avoiding future treatment costs?

Why are donors so reluctant to find $100 million to fund microbicide trials, which may have the potential to avert billions of dollars in future treatment costs?

15 September 2010
Center for Global Development Global Health Policy blog
Money missing to confirm trial of microbicide against HIV

Donors have not committed enough money for even one of the two studies needed to confirm a promising South African trial of the microbicide. Only about $58 million of the $100 million needed for follow-up research has been pledged, according to UNAIDS.

06 September 2010
New York Times
Funding shortage stymies a promising AIDS advance

Two additional studies are needed to confirm that a gel would significantly protect women from HIV.

04 September 2010
Chicago Star-Tribune
← Prev1...1213141516Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.